In the study by Baneckova et al. SOX-10 and S1009 protein expression was evaluated in 89 benign tumors, including 74 oncocytomas, 15 pleomorphic adenomas (PA), and myoepitheliomas (ME) with oncocytic metaplasia. This evidence concerns the gene SOX10 and oncocytic adenoma.